D.A. Davidson & Co’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

D.A. Davidson & Co’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-116	Closed	-$6K	–	2497
2016 Q1	$6K	Hold	116	–	–	﹤0.01%	2030
2015 Q4	$13K	Hold	116	–	–	﹤0.01%	1849
2015 Q3	$13K	Buy	116 +65	+127%	+$8.49K	﹤0.01%	1811
2015 Q2	$3K	Buy	+51	New	+$3.34K	﹤0.01%	2098

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

D.A. Davidson & Co's ANAC Position: Q2 2016 in Review

D.A. Davidson & Co sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 116 shares — an estimated $6K sold.

D.A. Davidson & Co first reported a position in ANAC in Q2 2015 and held it in 4 quarters. The position peaked at $13K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

D.A. Davidson & Co reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
D.A. Davidson & Co sold 116 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $6K.
D.A. Davidson & Co first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2015 and held it in 4 quarters.
D.A. Davidson & Co's ANACOR PHARMACEUTICALS INC COM position peaked at $13K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on D.A. Davidson & Co's 13F filing for Q2 2016, filed 15 Aug 2016.